Aimmune Therapeutics, Inc. echanj aksyon nan dola istwa pri, tablo pou Avril 2017
Sityasyon yo de aksyon yo nan Aimmune Therapeutics, Inc. nan Avril 2017 chanje a -5.694%. Pri ki pi ba a de aksyon yo nan Aimmune Therapeutics, Inc. nan Avril 2017 te 18.88 US dola. Valè ki pi wo a AIMT aksyon nan Avril 2017 te 21.08 US dola.
Montre:
Aimmune Therapeutics, Inc. (AIMT)
Pou
US dola (USD)
Aimmune Therapeutics, Inc. US dola valè istwa
Oktòb 2020
Septanm 2020
Out 2020
Jiyè 2020
Jen 2020
Me 2020
Avril 2020
Mas 2020
Fevriye 2020
Janvye 2020
Desanm 2019
Novanm 2019
Oktòb 2019
Septanm 2019
Out 2019
Jiyè 2019
Jen 2019
Me 2019
Avril 2019
Mas 2019
Fevriye 2019
Janvye 2019
Desanm 2018
Novanm 2018
Oktòb 2018
Septanm 2018
Out 2018
Jiyè 2018
Jen 2018
Me 2018
Avril 2018
Mas 2018
Fevriye 2018
Janvye 2018
Desanm 2017
Novanm 2017
Oktòb 2017
Septanm 2017
Out 2017
Jiyè 2017
Jen 2017
Me 2017
Avril 2017
Mas 2017
Fevriye 2017
Janvye 2017
Desanm 2016
Novanm 2016
Oktòb 2016
Septanm 2016
Out 2016
Jiyè 2016
Jen 2016
Me 2016
Avril 2016
Mas 2016
Fevriye 2016
Janvye 2016
Desanm 2015
Novanm 2015
Oktòb 2015
Septanm 2015
Out 2015
Dat
To
30/04/2017
18.88 USD
29/04/2017
19.04 USD
28/04/2017
19.44 USD
27/04/2017
19.67 USD
26/04/2017
19.62 USD
25/04/2017
19.53 USD
24/04/2017
19.29 USD
23/04/2017
19.79 USD
22/04/2017
19.8 USD
21/04/2017
19.07 USD
20/04/2017
19.65 USD
19/04/2017
19.75 USD
18/04/2017
19.42 USD
17/04/2017
19.62 USD
16/04/2017
19.57 USD
15/04/2017
19.44 USD
14/04/2017
19.67 USD
13/04/2017
19.57 USD
12/04/2017
19.57 USD
11/04/2017
19.7 USD
10/04/2017
19.76 USD
09/04/2017
19.65 USD
08/04/2017
19.75 USD
07/04/2017
20.02 USD
06/04/2017
20.31 USD
05/04/2017
20.51 USD
04/04/2017
20.96 USD
03/04/2017
21.08 USD
02/04/2017
19.76 USD
01/04/2017
20.02 USD
Pri a de aksyon Aimmune Therapeutics, Inc.
Aksyon AIMT Online
Aimmune Therapeutics, Inc. an tan reyèl stock site, AIMT pri sou entènèt pri, AIMT tablo.
Aksyon AIMT Online
Finans Aimmune Therapeutics, Inc.
Pwofi Aimmune Therapeutics, Inc.
Rapò sou rezilta finansye yo nan konpayi an Aimmune Therapeutics, Inc., Aimmune Therapeutics, Inc. anyèl revni pou 2024.
Pwofi Aimmune Therapeutics, Inc.
